CIBC World Market’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,499
Closed -$246K 1466
2025
Q4
$246K Buy
13,499
+3,201
+31% +$53.9K ﹤0.01% 1322
2025
Q3
$151K Buy
+10,298
New +$177K ﹤0.01% 1363
2025
Q1
Sell
-12,935
Closed -$222K 1353
2024
Q4
$222K Buy
12,935
+760
+6% +$14.3K ﹤0.01% 1270
2024
Q3
$243K Sell
12,175
-3,558
-23% -$55.3K ﹤0.01% 1189
2024
Q2
$176K Buy
15,733
+1
+0% +$8 ﹤0.01% 1200
2024
Q1
$104K Buy
15,732
+533
+4% +$2.91K ﹤0.01% 1253
2023
Q4
$69K Buy
15,199
+4,732
+45% +$17.5K ﹤0.01% 1215
2023
Q3
$37K Buy
+10,467
New +$40.3K ﹤0.01% 1199
2020
Q1
Sell
-37,900
Closed -$152K 981
2019
Q4
$152K Sell
37,900
-151,700
-80% -$661K ﹤0.01% 1080
2019
Q3
$844K Buy
+189,600
New +$792K ﹤0.01% 676

Other funds holding ADMA

CIBC World Market's ADMA Position: Q1 2026 in Review

CIBC World Market sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 13,499 shares — an estimated $246K sold.

CIBC World Market first reported a position in ADMA in Q3 2019 and held it in 10 quarters. The position peaked at $844K in Q3 2019. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • CIBC World Market reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • CIBC World Market sold 13,499 ADMA Biologics shares in Q1 2026, an estimated $246K.
  • CIBC World Market first reported a position in ADMA Biologics in Q3 2019 and held it in 10 quarters.
  • CIBC World Market's ADMA Biologics position peaked at $844K in Q3 2019.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.